chr6_-_32605898
|
2.353
|
NM_002125
|
HLA-DRB5
|
major histocompatibility complex, class II, DR beta 5
|
chr5_-_149772563
|
2.331
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
chr10_-_90702490
|
2.131
|
NM_001613
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
chr11_-_110755112
|
2.061
|
|
POU2AF1
|
POU class 2 associating factor 1
|
chr6_-_41823056
|
2.047
|
NM_001166424
NM_002630
|
PGC
|
progastricsin (pepsinogen C)
|
chr17_-_35975227
|
1.975
|
NM_001838
|
CCR7
|
chemokine (C-C motif) receptor 7
|
chr2_+_17585462
|
1.972
|
|
VSNL1
|
visinin-like 1
|
chr10_-_98021144
|
1.675
|
NM_001114094
NM_013314
|
BLNK
|
B-cell linker
|
chr2_+_228386800
|
1.663
|
NM_001130046
NM_004591
|
CCL20
|
chemokine (C-C motif) ligand 20
|
chr14_+_105024576
|
1.637
|
|
CRIP1
|
cysteine-rich protein 1 (intestinal)
|
chr6_-_31432954
|
1.409
|
NM_005514
|
HLA-B
|
major histocompatibility complex, class I, B
|
chr4_+_74497998
|
1.401
|
|
ALB
|
albumin
|
chr6_-_32665409
|
1.340
|
NM_002124
|
HLA-DRB1
HLA-DRB4
HLA-DRB5
|
major histocompatibility complex, class II, DR beta 1
major histocompatibility complex, class II, DR beta 4
major histocompatibility complex, class II, DR beta 5
|
chr3_+_180853473
|
1.291
|
NM_003940
|
USP13
|
ubiquitin specific peptidase 13 (isopeptidase T-3)
|
chr5_+_118632403
|
1.281
|
|
TNFAIP8
|
tumor necrosis factor, alpha-induced protein 8
|
chr6_+_32515596
|
1.265
|
NM_019111
|
HLA-DRA
|
major histocompatibility complex, class II, DR alpha
|
chr9_+_2612052
|
1.244
|
|
VLDLR
|
very low density lipoprotein receptor
|
chr8_+_123863169
|
1.231
|
|
ZHX2
|
zinc fingers and homeoboxes 2
|
chr5_+_118632316
|
1.230
|
NM_001077654
|
TNFAIP8
|
tumor necrosis factor, alpha-induced protein 8
|
chr4_+_74498042
|
1.229
|
|
ALB
|
albumin
|
chr3_-_55490401
|
1.220
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
chr5_-_149772469
|
1.200
|
NM_001025159
NM_004355
NM_001025158
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
chr8_+_123863075
|
1.187
|
NM_014943
|
ZHX2
|
zinc fingers and homeoboxes 2
|
chr2_+_17585287
|
1.182
|
NM_003385
|
VSNL1
|
visinin-like 1
|
chr11_-_110755366
|
1.123
|
NM_006235
|
POU2AF1
|
POU class 2 associating factor 1
|
chr14_-_106249999
|
1.117
|
|
IGHA1
|
immunoglobulin heavy constant alpha 1
|
chr10_+_7785347
|
1.108
|
|
ITIH2
|
inter-alpha (globulin) inhibitor H2
|
chr10_+_7785331
|
1.108
|
|
ITIH2
|
inter-alpha (globulin) inhibitor H2
|
chr2_-_220144427
|
1.101
|
|
OBSL1
|
obscurin-like 1
|
chr14_-_88953059
|
1.089
|
NM_005197
|
FOXN3
|
forkhead box N3
|
chr3_+_134978615
|
1.068
|
|
TF
|
transferrin
|
chr10_+_7785360
|
1.057
|
|
ITIH2
|
inter-alpha (globulin) inhibitor H2
|
chr10_+_7785290
|
1.021
|
|
ITIH2
|
inter-alpha (globulin) inhibitor H2
|
chr6_-_31432877
|
1.005
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
chr3_+_187813405
|
0.997
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
chr10_+_7785235
|
0.994
|
NM_002216
|
ITIH2
|
inter-alpha (globulin) inhibitor H2
|
chr5_-_42847716
|
0.990
|
NM_001085486
NM_001093726
NM_005410
|
SEPP1
|
selenoprotein P, plasma, 1
|
chr1_-_111544820
|
0.968
|
|
DENND2D
|
DENN/MADD domain containing 2D
|
chr3_+_187813538
|
0.967
|
NM_001622
|
AHSG
|
alpha-2-HS-glycoprotein
|
chr3_+_187813553
|
0.950
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
chr3_+_123256902
|
0.945
|
NM_175862
|
CD86
|
CD86 molecule
|
chr16_-_87244896
|
0.938
|
NM_000101
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
chr17_-_6958282
|
0.930
|
NM_080914
|
ASGR2
|
asialoglycoprotein receptor 2
|
chr7_+_94130752
|
0.925
|
|
PEG10
|
paternally expressed 10
|
chr1_-_25129354
|
0.925
|
NM_004350
|
RUNX3
|
runt-related transcription factor 3
|
chr12_+_7039453
|
0.919
|
|
|
|
chr6_-_31432934
|
0.905
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
chr12_-_101835026
|
0.902
|
|
PAH
|
phenylalanine hydroxylase
|
chr6_+_29963485
|
0.900
|
|
|
|
chr4_-_110942576
|
0.898
|
|
CFI
|
complement factor I
|
chr10_-_95350949
|
0.894
|
NM_006744
|
RBP4
|
retinol binding protein 4, plasma
|
chr2_-_237987509
|
0.883
|
|
COL6A3
|
collagen, type VI, alpha 3
|
chr16_+_55963899
|
0.883
|
NM_002996
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
chr14_-_105804211
|
0.877
|
|
IGHG1
|
immunoglobulin heavy constant gamma 1 (G1m marker)
|
chr4_+_74493218
|
0.869
|
|
ALB
|
albumin
|
chr3_-_79899748
|
0.869
|
NM_002941
|
ROBO1
|
roundabout, axon guidance receptor, homolog 1 (Drosophila)
|
chr9_+_116125123
|
0.869
|
NM_000607
|
ORM1
|
orosomucoid 1
|
chr8_-_122722674
|
0.867
|
NM_005328
|
HAS2
|
hyaluronan synthase 2
|
chr1_+_63861474
|
0.859
|
NM_001172818
|
PGM1
|
phosphoglucomutase 1
|
chr14_-_105476678
|
0.844
|
|
IGHM
|
immunoglobulin heavy constant mu
|
chr7_+_26298018
|
0.829
|
NM_013322
|
SNX10
|
sorting nexin 10
|
chr7_+_26298136
|
0.826
|
|
SNX10
|
sorting nexin 10
|
chr12_+_79995927
|
0.823
|
NM_024560
|
ACSS3
|
acyl-CoA synthetase short-chain family member 3
|
chr19_-_6671585
|
0.819
|
NM_000064
|
C3
|
complement component 3
|
chr5_+_52812236
|
0.806
|
NM_006350
NM_013409
|
FST
|
follistatin
|
chr2_-_237987579
|
0.804
|
NM_004369
NM_057164
NM_057165
NM_057166
NM_057167
|
COL6A3
|
collagen, type VI, alpha 3
|
chr2_+_231437905
|
0.801
|
|
ITM2C
|
integral membrane protein 2C
|
chr2_-_238861830
|
0.791
|
NM_022817
|
PER2
|
period homolog 2 (Drosophila)
|
chr6_+_29963328
|
0.788
|
|
HLA-H
|
major histocompatibility complex, class I, H (pseudogene)
|
chrX_-_32083506
|
0.783
|
NM_004013
NM_004020
NM_004021
NM_004022
NM_004023
|
DMD
|
dystrophin
|
chr7_-_86686754
|
0.780
|
NM_024315
|
C7orf23
|
chromosome 7 open reading frame 23
|
chr6_-_31432543
|
0.778
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
chr2_+_231437882
|
0.775
|
|
ITM2C
|
integral membrane protein 2C
|
chr2_-_109728958
|
0.774
|
NM_144710
NM_178584
|
SEPT10
|
septin 10
|
chr1_-_219982081
|
0.773
|
NM_007207
NM_144729
|
DUSP10
|
dual specificity phosphatase 10
|
chr17_-_26672757
|
0.770
|
NM_001003927
NM_014210
|
EVI2A
|
ecotropic viral integration site 2A
|
chr7_+_94130673
|
0.761
|
|
PEG10
|
paternally expressed 10
|
chr19_+_44590345
|
0.760
|
|
ZFP36
|
zinc finger protein 36, C3H type, homolog (mouse)
|
chr2_+_86521999
|
0.756
|
NM_001146688
|
KDM3A
|
lysine (K)-specific demethylase 3A
|
chr1_-_111544784
|
0.756
|
NM_024901
|
DENND2D
|
DENN/MADD domain containing 2D
|
chr3_-_115826481
|
0.754
|
NM_001164346
|
ZBTB20
|
zinc finger and BTB domain containing 20
|
chr5_-_1547872
|
0.753
|
|
LPCAT1
|
lysophosphatidylcholine acyltransferase 1
|
chr6_+_32713160
|
0.751
|
NM_002122
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
chr4_-_110942783
|
0.749
|
NM_000204
|
CFI
|
complement factor I
|
chr14_-_106184988
|
0.735
|
|
IGHA1
IGHG1
|
immunoglobulin heavy constant alpha 1
immunoglobulin heavy constant gamma 1 (G1m marker)
|
chr1_-_219982016
|
0.728
|
|
DUSP10
|
dual specificity phosphatase 10
|
chr9_+_2611740
|
0.720
|
NM_001018056
NM_003383
|
VLDLR
|
very low density lipoprotein receptor
|
chr9_+_2612099
|
0.718
|
|
VLDLR
|
very low density lipoprotein receptor
|
chr2_+_231437867
|
0.710
|
|
ITM2C
|
integral membrane protein 2C
|
chr6_+_30018287
|
0.706
|
NM_002116
|
HLA-A
|
major histocompatibility complex, class I, A
|
chr12_-_101835183
|
0.704
|
|
PAH
|
phenylalanine hydroxylase
|
chr6_-_16869579
|
0.704
|
NM_000332
NM_001128164
|
ATXN1
|
ataxin 1
|
chr1_-_25128951
|
0.704
|
|
RUNX3
|
runt-related transcription factor 3
|
chr9_+_116131889
|
0.701
|
NM_000608
|
ORM2
|
orosomucoid 2
|
chr3_+_106568334
|
0.698
|
NM_001627
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
chr9_+_2612134
|
0.696
|
|
VLDLR
|
very low density lipoprotein receptor
|
chrX_+_128741562
|
0.684
|
NM_018990
|
SASH3
|
SAM and SH3 domain containing 3
|
chr1_-_56817823
|
0.684
|
NM_003713
|
PPAP2B
|
phosphatidic acid phosphatase type 2B
|
chr11_-_70185559
|
0.680
|
NM_133266
|
SHANK2
|
SH3 and multiple ankyrin repeat domains 2
|
chr3_+_123036719
|
0.679
|
NM_018456
|
EAF2
|
ELL associated factor 2
|
chr2_+_86521939
|
0.679
|
|
KDM3A
|
lysine (K)-specific demethylase 3A
|
chrX_+_128741578
|
0.675
|
|
SASH3
|
SAM and SH3 domain containing 3
|
chr1_+_210805319
|
0.671
|
NM_001030287
|
ATF3
|
activating transcription factor 3
|
chr4_+_74520796
|
0.666
|
NM_001134
|
AFP
|
alpha-fetoprotein
|
chr20_-_51633042
|
0.662
|
NM_006526
|
ZNF217
|
zinc finger protein 217
|
chr19_+_44591589
|
0.662
|
|
|
|
chr11_+_1846478
|
0.661
|
NM_001013253
|
LSP1
|
lymphocyte-specific protein 1
|
chr2_+_109729176
|
0.660
|
NM_023016
|
ANKRD57
|
ankyrin repeat domain 57
|
chr6_+_32003180
|
0.657
|
NM_000063
NM_001145903
|
C2
|
complement component 2
|
chr2_+_68445936
|
0.652
|
|
PLEK
|
pleckstrin
|
chr20_+_45564063
|
0.651
|
|
NCOA3
|
nuclear receptor coactivator 3
|
chr5_+_135392482
|
0.649
|
NM_000358
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
chr17_-_26665213
|
0.648
|
|
EVI2B
|
ecotropic viral integration site 2B
|
chr3_+_101694244
|
0.643
|
|
TMEM45A
|
transmembrane protein 45A
|
chr5_+_52812165
|
0.640
|
|
FST
|
follistatin
|
chr1_-_25164061
|
0.639
|
NM_001031680
|
RUNX3
|
runt-related transcription factor 3
|
chr2_-_220144511
|
0.639
|
NM_001173408
NM_001173431
NM_015311
|
OBSL1
|
obscurin-like 1
|
chr17_-_26665220
|
0.636
|
NM_006495
|
EVI2B
|
ecotropic viral integration site 2B
|
chr9_+_111582317
|
0.636
|
NM_053016
NM_007203
NM_147150
|
PALM2
PALM2-AKAP2
|
paralemmin 2
PALM2-AKAP2 readthrough
|
chr16_-_11588525
|
0.635
|
|
LITAF
|
lipopolysaccharide-induced TNF factor
|
chr19_+_55614006
|
0.633
|
NM_003121
|
SPIB
|
Spi-B transcription factor (Spi-1/PU.1 related)
|
chr19_-_7672978
|
0.631
|
NM_002002
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
chr22_+_35586950
|
0.630
|
NM_000631
NM_013416
|
NCF4
|
neutrophil cytosolic factor 4, 40kDa
|
chr3_+_106568430
|
0.630
|
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
chr20_-_61028263
|
0.616
|
|
DIDO1
|
death inducer-obliterator 1
|
chr6_+_30018265
|
0.615
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
chr20_+_45564007
|
0.610
|
NM_001174087
NM_001174088
NM_006534
NM_181659
|
NCOA3
|
nuclear receptor coactivator 3
|
chr14_-_105542441
|
0.610
|
|
IGLJ3
IGHA1
IGHG1
IGHM
|
immunoglobulin lambda joining 3
immunoglobulin heavy constant alpha 1
immunoglobulin heavy constant gamma 1 (G1m marker)
immunoglobulin heavy constant mu
|
chr3_-_81893604
|
0.606
|
NM_000158
|
GBE1
|
glucan (1,4-alpha-), branching enzyme 1
|
chr22_-_35875890
|
0.603
|
NM_000878
|
IL2RB
|
interleukin 2 receptor, beta
|
chr3_-_188936941
|
0.602
|
NM_001130845
|
BCL6
|
B-cell CLL/lymphoma 6
|
chr5_+_133479196
|
0.594
|
NM_001134851
NM_201632
NM_201634
NM_213648
|
TCF7
|
transcription factor 7 (T-cell specific, HMG-box)
|
chr8_+_123863224
|
0.591
|
|
ZHX2
|
zinc fingers and homeoboxes 2
|
chr9_-_110736377
|
0.590
|
NM_003640
|
IKBKAP
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein
|
chr6_+_29799182
|
0.588
|
|
HLA-F
|
major histocompatibility complex, class I, F
|
chr10_-_74526596
|
0.588
|
|
P4HA1
|
prolyl 4-hydroxylase, alpha polypeptide I
|
chr6_-_32742265
|
0.587
|
NM_002123
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
chr21_-_45165249
|
0.587
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
chr5_-_150517499
|
0.586
|
|
ANXA6
|
annexin A6
|
chr7_+_94135384
|
0.583
|
|
PEG10
|
paternally expressed 10
|
chr22_+_20899155
|
0.583
|
|
|
|
chr3_-_81893506
|
0.582
|
|
GBE1
|
glucan (1,4-alpha-), branching enzyme 1
|
chr13_+_75232797
|
0.577
|
NM_015842
|
LMO7
|
LIM domain 7
|
chr2_-_37727472
|
0.577
|
|
CDC42EP3
|
CDC42 effector protein (Rho GTPase binding) 3
|
chr19_+_62394645
|
0.573
|
NM_003417
|
ZNF264
|
zinc finger protein 264
|
chr2_-_21079145
|
0.572
|
|
APOB
|
apolipoprotein B (including Ag(x) antigen)
|
chrM_+_13453
|
0.567
|
|
|
|
chr13_+_112825113
|
0.567
|
NM_000504
|
F10
|
coagulation factor X
|
chr17_-_26665194
|
0.566
|
|
EVI2B
|
ecotropic viral integration site 2B
|
chr4_+_100714995
|
0.565
|
|
MTTP
|
microsomal triglyceride transfer protein
|
chr10_-_74526662
|
0.565
|
NM_000917
NM_001017962
NM_001142595
NM_001142596
|
P4HA1
|
prolyl 4-hydroxylase, alpha polypeptide I
|
chr9_+_132310068
|
0.564
|
|
ASS1
|
argininosuccinate synthase 1
|
chr14_+_23633101
|
0.562
|
NM_001018073
NM_004563
|
PCK2
|
phosphoenolpyruvate carboxykinase 2 (mitochondrial)
|
chr21_-_45165204
|
0.562
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
chr14_+_94148466
|
0.559
|
NM_001085
|
SERPINA3
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3
|
chr16_+_30293598
|
0.558
|
NM_013292
|
MYLPF
|
myosin light chain, phosphorylatable, fast skeletal muscle
|
chr11_+_116575249
|
0.557
|
NM_001001522
NM_003186
|
TAGLN
|
transgelin
|
chr12_+_99391870
|
0.556
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
chr2_-_220144254
|
0.556
|
|
OBSL1
|
obscurin-like 1
|
chr11_-_2113297
|
0.555
|
|
IGF2
|
insulin-like growth factor 2 (somatomedin A)
|
chr3_-_180272291
|
0.553
|
NM_022470
NM_152240
|
ZMAT3
|
zinc finger, matrin-type 3
|
chr2_+_102345528
|
0.552
|
NM_003855
|
IL18R1
|
interleukin 18 receptor 1
|
chr5_+_53787187
|
0.545
|
NM_006308
|
HSPB3
|
heat shock 27kDa protein 3
|
chr2_+_85665041
|
0.544
|
NM_006634
|
VAMP5
|
vesicle-associated membrane protein 5 (myobrevin)
|
chr16_-_21197138
|
0.538
|
|
CRYM
|
crystallin, mu
|
chr3_-_81893308
|
0.538
|
|
GBE1
|
glucan (1,4-alpha-), branching enzyme 1
|
chr19_+_47073029
|
0.537
|
NM_001783
NM_021601
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha
|
chr5_-_150517528
|
0.536
|
NM_001155
|
ANXA6
|
annexin A6
|
chr12_+_51979721
|
0.535
|
NM_021640
|
C12orf10
|
chromosome 12 open reading frame 10
|
chr2_-_37752731
|
0.530
|
NM_006449
|
CDC42EP3
|
CDC42 effector protein (Rho GTPase binding) 3
|
chr8_-_17986690
|
0.530
|
NM_001127505
NM_004315
|
ASAH1
|
N-acylsphingosine amidohydrolase (acid ceramidase) 1
|
chr12_-_91063441
|
0.529
|
NM_001731
|
BTG1
|
B-cell translocation gene 1, anti-proliferative
|
chr1_-_145163779
|
0.528
|
NM_001144829
NM_001144830
NM_001461
|
FMO5
|
flavin containing monooxygenase 5
|
chr1_-_172153087
|
0.525
|
NM_000488
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
chr10_+_76256305
|
0.525
|
NM_012330
|
MYST4
|
MYST histone acetyltransferase (monocytic leukemia) 4
|
chr5_+_156628929
|
0.524
|
NM_014376
|
CYFIP2
|
cytoplasmic FMR1 interacting protein 2
|
chr7_-_99411573
|
0.524
|
NM_001185
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding
|
chr9_+_89302239
|
0.523
|
|
DAPK1
|
death-associated protein kinase 1
|
chr6_-_41811916
|
0.521
|
NM_001167827
|
TFEB
|
transcription factor EB
|
chr6_+_32003380
|
0.515
|
|
C2
|
complement component 2
|
chr3_-_184363157
|
0.515
|
NM_014398
|
LAMP3
|
lysosomal-associated membrane protein 3
|
chr1_-_154665807
|
0.513
|
NM_006365
|
C1orf61
|
chromosome 1 open reading frame 61
|
chrX_+_105823723
|
0.512
|
NM_024539
|
RNF128
|
ring finger protein 128
|
chrX_+_38305634
|
0.511
|
NM_004615
|
TSPAN7
|
tetraspanin 7
|
chr2_+_95055155
|
0.510
|
NM_002371
NM_022438
NM_022439
NM_022440
|
MAL
|
mal, T-cell differentiation protein
|
chr4_+_78297356
|
0.504
|
NM_004354
|
CCNG2
|
cyclin G2
|
chr12_+_99391681
|
0.502
|
NM_005123
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
chr6_-_31658044
|
0.501
|
NM_002341
NM_009588
|
LTB
|
lymphotoxin beta (TNF superfamily, member 3)
|
chr5_-_111120929
|
0.500
|
NM_001142482
NM_001142481
|
C5orf13
|
chromosome 5 open reading frame 13
|
chr14_+_64948332
|
0.499
|
|
FUT8
|
fucosyltransferase 8 (alpha (1,6) fucosyltransferase)
|
chr4_+_74491272
|
0.497
|
|
ALB
|
albumin
|
chr1_-_172153024
|
0.495
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
chr11_+_73037382
|
0.492
|
NM_001130036
|
PLEKHB1
|
pleckstrin homology domain containing, family B (evectins) member 1
|
chr6_-_32929721
|
0.487
|
NM_000593
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
|
chr3_-_180272229
|
0.487
|
|
ZMAT3
|
zinc finger, matrin-type 3
|
chr1_-_56817802
|
0.483
|
|
PPAP2B
|
phosphatidic acid phosphatase type 2B
|
chr3_-_121884091
|
0.483
|
NM_000187
|
HGD
|
homogentisate 1,2-dioxygenase
|
chr16_+_80370426
|
0.483
|
NM_002661
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
chr4_+_3737872
|
0.481
|
|
ADRA2C
|
adrenergic, alpha-2C-, receptor
|
chr1_+_154386358
|
0.475
|
NM_001193301
|
SEMA4A
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A
|